CHEMED CORPORATION

Analyst Reco. Chemed Corporation

Equities

CHE

US16359R1032

Market Closed - Nyse Other stock markets 04:00:02 2024-04-16 pm EDT			5-day change	1st Jan Change
610 ^USD	-0.96%		-2.42%	+4.31%

Apr. 08	Chemed Corporation Receives Shareholders Proposal from John Chevedden	CI
Apr. 01	Chemed Insider Sold Shares Worth $1,283,300, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing	Mar. 22	MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing	Mar. 22	MT
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept	Mar. 04	MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating	Feb. 29	MT
Oppenheimer Adjusts Chemed Price Target to $625 From $590, Maintains Outperform Rating	Jan. 17	MT
RBC Raises Price Target on Chemed to $604 From $576, Keeps Outperform Rating	23-10-30	MT
RBC Cuts Price Target on Chemed to $576 From $610, Maintains Outperform Rating	23-07-31	MT
Oppenheimer Adjusts Chemed Price Target to $590 From $610, Maintains Outperform Rating	23-07-27	MT
RBC Boosts Price Target on Chemed to $610 From $587 After 'Solid Results,' Maintains Outperform Rating	23-05-01	MT
Oppenheimer Raises Chemed's Price Target to $610 From $580, Maintains Outperform Rating	23-04-28	MT
RBC Raises Price Target on Chemed to $587 From $545, Maintains Outperform Rating	23-02-27	MT
RBC Raises Price Target on Chemed to $545 From $541, Maintains Outperform Rating	22-11-03	MT
RBC Cuts Price Target on Chemed to $541 From $592, Citing Recent Industry Multiple Compression, Maintains Outperform Rating	22-08-01	MT
RBC Boosts Price Target on Chemed to $592 From $579, Maintains Outperform Rating	22-04-28	MT
RBC Cuts Price Target on Chemed to $579 From $609, Maintains Outperform Rating	22-03-04	MT
CHEMED : RBC Boosts Price Target on Chemed to $609 From $604, Citing Strong Roto-Rooter Growth, Maintains Outperform Rating	21-07-29	MT
CHEMED : RBC Boosts Price Target on Chemed to $604 From $600, Sees Guidance Raise Likely, Maintains Outperform Rating	21-05-10	MT
CHEMED : Oppenheimer Adjusts Chemed PT to $580 From $600, Maintains Outperform Rating	21-02-25	MT
CHEMED : Oppenheimer Adjusts Chemed's Price Target to $600 From $535, Maintains Outperform Rating	21-01-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer